| 1/17/2024 | 30049049 | Anifrolumab (MEDI-546) 150mg/mL/Placebo, concentrated solution for mixing intravenous infusion solution, 1 box includes 1 vial of 2ml. Lot number 30424.11/1. Deadline June 30, 2025. Manufacturer AstraZeneca Nijmegen BV 100% new product | XXXXXXXXXX | 15 | Box/Bag/Pack | 1641.88635 | Netherland | NA |
| 1/17/2024 | 30049049 | Anifrolumab (MEDI-546) 150mg/mL/Placebo, concentrated solution for mixing intravenous infusion solution, 1 box includes 1 vial of 2ml. Lot number 30424.11/1. Deadline June 30, 2025. Manufacturer AstraZeneca Nijmegen BV 100% new product | XXXXXXXXXX | 45 | Box/Bag/Pack | 4925.65905 | Netherland | NA |
| 1/16/2024 | 30049049 | Anifrolumab (MEDI-546) 150mg/mL/Placebo, concentrated solution for mixing intravenous infusion solution, 1 box includes 1 vial of 2ml. Lot number 30424.11/1. Deadline June 30, 2025. Manufacturer AstraZeneca Nijmegen BV 100% new product | XXXXXXXXXX | 34 | Box/Bag/Pack | 3721.60906 | Netherland | NA |
| 1/16/2024 | 30049049 | Anifrolumab (MEDI-546) 150mg/mL/Placebo, concentrated solution for mixing intravenous infusion solution, 1 box includes 1 vial of 2ml. Lot number 30424.11/1. Deadline June 30, 2025. Manufacturer AstraZeneca Nijmegen BV 100% new product | XXXXXXXXXX | 18 | Box/Bag/Pack | 1970.26362 | Netherland | NA |
| 1/16/2024 | 30049049 | Anifrolumab (MEDI-546) 150mg/mL/Placebo, concentrated solution for mixing intravenous infusion solution, 1 box includes 1 vial of 2ml. Lot number 30424.11/1. Deadline June 30, 2025. Manufacturer AstraZeneca Nijmegen BV 100% new product | XXXXXXXXXX | 38 | Box/Bag/Pack | 4159.44542 | Netherland | NA |
| 1/16/2024 | 30049049 | Anifrolumab (MEDI-546) 150mg/mL/Placebo, concentrated solution for mixing intravenous infusion solution, 1 box includes 1 vial of 2ml. Lot number 30424.6/1. Deadline August 31, 2024. Manufacturer AstraZeneca Nijmegen BV 100% new product | XXXXXXXXXX | 48 | Box/Bag/Pack | 5254.03632 | Netherland | NA |
| 1/16/2024 | 30049049 | Anifrolumab (MEDI-546) 150mg/mL/Placebo, concentrated solution for mixing intravenous infusion solution, 1 box includes 1 vial of 2ml. Lot number 30424.11/1. Deadline June 30, 2025. Manufacturer AstraZeneca Nijmegen BV 100% new product | XXXXXXXXXX | 34 | Box/Bag/Pack | 3721.60906 | Netherland | NA |
| 1/16/2024 | 30049049 | Anifrolumab (MEDI-546) 150mg/mL/Placebo, concentrated solution for mixing intravenous infusion solution, 1 box includes 1 vial of 2ml. Lot number 30424.6/1. Deadline August 31, 2024. Manufacturer AstraZeneca Nijmegen BV 100% new product | XXXXXXXXXX | 6 | Box/Bag/Pack | 656.75454 | Netherland | NA |
| 1/16/2024 | 30049049 | Anifrolumab (MEDI-546) 150mg/mL/Placebo, concentrated solution for mixing intravenous infusion solution, 1 box includes 1 vial of 2ml. Lot number 30424.6/1. Deadline August 31, 2024. Manufacturer AstraZeneca Nijmegen BV 100% new product | XXXXXXXXXX | 6 | Box/Bag/Pack | 656.75454 | Netherland | NA |
| 1/15/2024 | 30049049 | Anifrolumab (MEDI-546) 150mg/mL/Placebo, concentrated solution for mixing intravenous infusion solution, 1 box includes 1 vial of 2ml. Lot number 30424.11/1. Deadline June 30, 2025. Manufacturer AstraZeneca Nijmegen BV 100% new product | XXXXXXXXXX | 12 | Box/Bag/Pack | 1313.50908 | Netherland | NA |